Netherlands: Limitation of claim changes in appeal

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Netherlands: Limitation of claim changes in appeal

In Dutch court practice, an appeal is of a devolutive nature, that is in appeal the case is reconsidered as a whole. However, in a recent interlocutory decision (November 3 2015, High Point v KPN), the Appeal Court in The Hague found that the patentee was not entitled to further limit his claims.

During the first instance case, High Point had already filed three sets of limited claims on which the court had based its decision. With the statement of appeal, High Point attacked the decision of the court of first instance and only later, although clearly in advance of the oral hearing, did High Point file a new set of further limited claims.

High Point's arguments that these new claims would simplify and accelerate the procedure, that it would always be possible to decrease the demand of relief and/or that the EPC would give the patentee the right to limit the patent, were not convincing. The appeal court determined that such a late filing of a limited claim set would not fit with the practice that in appeal no new facts or arguments are filed after the statement of appeal that could start a new discussion between parties.

On the other hand, the argument from KPN that by introducing this new set of claims High Point has abandoned the claim sets that were on file, was not accepted by the court, either.

This (interlocutory) decision now has the consequence that the case will proceed on the basis of the three claim sets on which the court in first instance has decided.

Bart van Wezenbeek


V.O.Johan de Wittlaan 72517 JR The HagueThe NetherlandsTel: +31 70 416 67 11Fax: +31 70 416 67 99info@vo.euwww.vo.eu

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article